-
Novel Value Elements: Developing and Applying a Pragmatic Framework in Early Stages of Product Development
Mar 10, 2025, 14:00 PM -
Anemia-Related Survival of Patients with Myelofibrosis: A Retrospective Real-World Study
Mar 10, 2025, 14:00 PM -
Real-World Clinical Outcomes, Healthcare Resource Utilization, and Direct Medical Costs in Atrial Fibrillation Patients Receiving Catheter Ablation in Japan
Mar 10, 2025, 14:00 PM -
Identifying Redundant or Misfitting Items Using Item Response Theory: Type I and II Error Rates for Item Local Dependence and Misfit Detection in Clinical Outcome Assessments
Mar 10, 2025, 14:00 PM -
Assessment of Real-World Adverse Events Associated with Ozanimod in Relapsing Remitting Multiple Sclerosis (RRMS)
Mar 10, 2025, 14:00 PM -
Potential Added Clinical Value of Polygenic Risk Scores in Risk Assessment of Atherosclerotic Cardiovascular Disease
Mar 10, 2025, 14:00 PM -
Examining Patterns in Breast Cancer Patient Characteristics and Treatment Throughout the COVID-19 Pandemic
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Dostarlimab Plus Chemotherapy As First-Line Treatment for Metastatic Non-Squamous Non-Small Cell Lung Cancer in Japan
Mar 10, 2025, 14:00 PM -
Prenatal Exposure to Antiseizure Medications and Congenital Malformation Risk in Offspring:A Population-Based Study
Mar 10, 2025, 14:00 PM -
Developing a Budget Impact R Shiney Application to Assess the Financial Implications of Implementing Organized Cancer Screening Programs in Countries with Limited Resources: Breast Cancer as an Example
Mar 10, 2025, 14:00 PM -
Health and Economic Value of Pneumococcal Conjugate Vaccine Against Antimicrobial Resistance in Brazil: An Agent-based Simulation Study
Mar 10, 2025, 14:00 PM -
Estimates of the Public Health Impact of Norovirus Vaccination for Older Adults in the United States
Mar 10, 2025, 14:00 PM -
Clinical Value of Testing for c-Met Protein Overexpression in Patients With Non-Small Cell Lung Cancer
Mar 10, 2025, 14:00 PM -
Unveiling the Impact: Economic and Resource Utilization Analysis of Drug-Resistant Epilepsy Patients in the US
Mar 10, 2025, 14:00 PM -
Evaluating the Cost-Effectiveness of Wastewater-Based Disease Surveillance
Mar 10, 2025, 14:00 PM -
Comparative Efficacy, Safety, and Tolerability of Xanomeline and Trospium Chloride versus Eight Atypical Antipsychotics for the Acute Treatment of Adults with Schizophrenia - A Network Meta-Analysis
Mar 10, 2025, 14:00 PM -
Risk of Cutaneous Adverse Drug Reactions with GLP-1 Receptor Agonists: Insights from FAERS and Systematic Review
Mar 10, 2025, 14:00 PM -
Does a Digital Health Program Influence One’s Choice of Traditional Health Care? Changes in Health Care Use and Episodic Cost Among a Group of Chronic MSK Patients in a Digital Conservative Musculoskeletal Care Program
Mar 10, 2025, 14:00 PM -
Selection and Stability of Parametric Bivariate Copula Models for Joint Modelling of Overall and Progression-Free Survival
Mar 10, 2025, 14:00 PM -
Real-World Healthcare Resource Utilization Patterns Among Patients With Non-Small Cell Lung Cancer Treated With Amivantamab Monotherapy
Mar 10, 2025, 14:00 PM
